title: Recombinant human interferon gamma: adverse effects in high-risk stage I and II cutaneous malignant melanoma.
authors.forename: F L
authors.initials: FL
authors.lastname: Meyskens
authors.forename: K
authors.initials: K
authors.lastname: Kopecky
authors.forename: M
authors.initials: M
authors.lastname: Samson
authors.forename: E
authors.initials: E
authors.lastname: Hersh
authors.forename: J
authors.initials: J
authors.lastname: Macdonald
authors.forename: H
authors.initials: H
authors.lastname: Jaffe
authors.forename: J
authors.initials: J
authors.lastname: Crowley
authors.forename: C
authors.initials: C
authors.lastname: Coltman
mesh_terms: D006801:Humans; D007371:Interferon-gamma / Q000009:adverse effects*; D008545:Melanoma / Q000628:therapy*; D009367:Neoplasm Staging; D011994:Recombinant Proteins; D012878:Skin Neoplasms / Q000628:therapy*
chemical_list: D011994:Recombinant Proteins; D007371:Interferon-gamma